Women's healthcare vendor Hologic has received U.S. Food and Drug Administration (FDA) clearance to incorporate body composition assessment into its Discovery dual-energy x-ray absorptiometry (DEXA) systems.
The U.S. National Health and Nutrition Examination Survey (NHANES) whole-body reference data are useful for managing diseases and conditions when the disease or condition itself, or its treatment, can affect the relative amounts of fat and lean tissue in the patient, according to the vendor.
